News United Therapeutics Corporation

Equities

UTHR

US91307C1027

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2024-12-13 pm EST			5-day change	1st Jan Change
361.81 ^USD	+0.06%		-2.13%	+64.54%

Dec. 10	United Therapeutics Insider Sold Shares Worth $3,676,877, According to a Recent SEC Filing	MT
Nov. 22	United Therapeutics Insider Sold Shares Worth $2,828,672, According to a Recent SEC Filing	MT

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

United Therapeutics Insider Sold Shares Worth $3,676,877, According to a Recent SEC Filing	Dec. 10	MT
United Therapeutics Insider Sold Shares Worth $2,828,672, According to a Recent SEC Filing	Nov. 22	MT
United Therapeutics Corporation Presents at UBS Global Healthcare Conference 2024, Nov-12-2024 02:45 PM	Nov. 12
United Therapeutics Corporation to Present at the UBS Global Healthcare Conference	Nov. 05	BU
BETA Technologies, Inc. announced that it has received $318.437454 million in funding from Qatar Investment Authority, Fidelity Management & Research Company LLC, TPG Capital, L.P., United Therapeutics Corporation and other investors	Oct. 30	CI
United Therapeutics Seeks M&A	Oct. 30	CI
United Therapeutics Corporation, Q3 2024 Earnings Call, Oct 30, 2024	Oct. 30
United Therapeutics' Q3 Earnings, Revenue Rise	Oct. 30	MT
United Therapeutics : Third Quarter 2024 Factsheet	Oct. 30	PU
United Therapeutics : Reports Third Quarter 2024 Financial Results Form 8 K	Oct. 30	PU
United Therapeutics : Third Quarter 2024 Financial Results Presentation	Oct. 30	PU
Earnings Flash (UTHR) UNITED THERAPEUTICS CORPORATION Posts Q3 Revenue $748.9M	Oct. 30	MT
United Therapeutics: Q3 Earnings Snapshot	Oct. 30	AQ
Tranche Update on United Therapeutics Corporation's Equity Buyback Plan announced on March 25, 2024.	Oct. 30	CI
United Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	Oct. 30	CI
United Therapeutics Corporation Reports Third Quarter 2024 Financial Results	Oct. 30	BU
BETA Technologies, Inc. announced a financing transaction	Oct. 23	CI
United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service	Oct. 23	BU
United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024	Oct. 23	BU
United Therapeutics Insider Sold Shares Worth $2,855,916, According to a Recent SEC Filing	Oct. 22	MT
Liquidia Corporation - United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics Patent	Oct. 08	AQ
Sector Update: Health Care Stocks Retreat Late Afternoon	Oct. 07	MT
Sector Update: Health Care Stocks Softer Monday Afternoon	Oct. 07	MT
Sector Update: Health Care	Oct. 07	MT
Liquidia Shares Jump After US Supreme Court Rejects United Therapeutics' Appeal in Patent Dispute	Oct. 07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News United Therapeutics Corporation

Equities

UTHR

US91307C1027

Biotechnology & Medical Research

Filters